Rejuvenate Bio is a biotechnology company developing gene therapy approaches to treat chronic, age-related diseases in humans, with research and product development across human therapies and the animal health pipeline. The company emphasizes advancing gene therapy trials and therapeutics designed to address age-related conditions. It communicates a focus on translating scientific research into therapies that could reduce the burden of chronic disease. Based on their site sections, they explore both human and animal health applications and have ongoing clinical and pipeline activities.
No recent news for this company.
No recent deals for this company.